Eyes Wide Open: Understanding and Preventing Ocular Complications in Aesthetic Medicine

Aesthetic injectables have transformed modern facial rejuvenation. Treatments such as dermal fillers, botulinum toxin, biostimulators, skin boosters and platelet-rich plasma (PRP) can achieve natural, confidence-building results when delivered by medically trained clinicians in a controlled environment. Yet even in expert hands, the potential for ocular complications, from mild ptosis to, in rare cases, blindness, demands continual vigilance and education.

A recently published narrative review in the Journal of Clinical Medicine (De-Pablo-Gómez-de-Liaño et al., 2025) summarised the incidence, clinical features, and management of ocular events following aesthetic treatments. The findings reinforce what ethical practitioners already practise: prevention, anatomical precision, and rapid recognition are the foundations of patient safety. [1]

When the Eyes Are at Risk

Ocular complications in aesthetics fall into three categories:

• Vascular events such as embolisation of filler into the ophthalmic or retinal arteries.

• Motor effects such as eyelid droop (ptosis) or diplopia from toxin diffusion.

• Surface disturbances including dryness, irritation, or periocular infection.

The Rare but Serious: Filler-Induced Blindness

The risk of blindness due to filler embolisation is estimated at around 1 in 100,000 injections. [3]

A landmark 2012 review by Lazzeri et al. first drew attention to cases of irreversible vision loss following injections with hyaluronic acid, silicone oil, and autologous fat. [2]

Of documented cases since then, 83 % involved hyaluronic-acid fillers, most commonly injected in the nasal dorsum and glabellar areas, regions directly connected to the ophthalmic artery. Alarmingly, 70 % of affected patients experienced no visual recovery despite immediate intervention.

More recently, PRP injections have also been implicated in rare visual loss through inadvertent arterial occlusion. [4]

The Common and Transient

Less catastrophic, but distressing, issues include:

• Palpebral ptosis (drooping eyelid) from botulinum toxin diffusion, resolving within weeks.

• Dry eye (≈ 3 %) due to reduced blinking or incomplete closure.

• Orbital cellulitis (≈ 6 %) requiring antibiotic management.

• Diplopia or oculomotor disturbance (< 2.5 %) that usually resolves spontaneously.

Why Knowledge of Anatomy Saves Sight

Every injector should understand that certain facial “danger zones” have direct vascular anastomoses to the eye. These include the glabella, nasal bridge, medial canthus and nasolabial region. Safe practice means:

• Using cannulas instead of needles in high-risk zones.

• Injecting slowly, at low pressure, in micro-boluses.

• Avoiding overfilling, especially along the nose and glabella.

• Having a hyaluronidase emergency kit and a referral pathway to ophthalmology.

• Maintaining detailed consent documentation, explicitly discussing ocular risk, however rare.

At Haus of Ästhetik, our protocols follow the guidance of the Joint Council for Cosmetic Practitioners (JCCP), Save Face, and UKHSA for complication recognition and escalation.

When Prevention Is Not Enough

If a patient experiences acute visual change, severe eye pain, ptosis, or blanching during an injection, seconds matter. Immediate steps include cessation of injection, emergency activation, high-dose hyaluronidase (for HA fillers), ocular massage, and urgent referral for ophthalmic intervention such as retrobulbar hyaluronidase or hyperbaric oxygen therapy. [3]

Prompt recognition remains the strongest predictor of functional recovery.

Product Longevity and Periocular Caution

Recent MRI studies by Mobin Master et al. demonstrate that hyaluronic-acid fillers can persist longer than advertised, particularly in less mobile areas like the tear trough. [5-7]

This persistence underscores why under-eye work must be approached with exceptional care, conservative volumes, and regular review. The periocular region’s naturally low hyaluronidase activity may explain delayed swelling or prolonged filler presence reported months later.

At Haus of Ästhetik, we prefer structural fillers such as Teoxane RHA 2/3 for mid-face support, while avoiding excessive volume near orbital vessels. For hydration, Mesoestetic Skinretin 0.3 and RHA HydroBoost serums provide cellular recovery without vascular risk, and are part of our post-procedure care.

Collaborating for Safer Outcomes

Ophthalmologists and aesthetic clinicians increasingly collaborate on shared-care protocols. Joint training sessions, simulation labs, and local referral partnerships are now encouraged across the UK.

We maintain a direct ophthalmology referral link for any periocular emergency and participate in peer-support complication groups such as the Aesthetic Complications Expert (ACE) Group. Continuous professional development and inter-disciplinary dialogue form the backbone of responsible practice.

Key Takeaways for Patients

• Choose a medically qualified injector working in a regulated clinic.

• Ask about complication protocols and emergency preparedness.

• Ensure your consent form explicitly mentions ocular risks.

• Report any visual or neurological symptoms immediately after treatment.

• Remember that cheaper or home-based services often mean higher risk.

References

1. De-Pablo-Gómez-de-Liaño L et al. Ophthalmological Complications of Aesthetic Medicine Procedures: A Narrative Review. J Clin Med 2025; 14(15): 5399.

2. Lazzeri D et al. Blindness following cosmetic injections of the face. Plast Reconstr Surg 2012; 129(4): 995-1012.

3. Foster J et al. Vision-Threatening Complications of Soft Tissue Fillers. Ophthalmology 2025; 132(8): 935-944.

4. Karam E et al. Visual Loss after Platelet-Rich Plasma Injection into the Face. Neuro-Ophthalmology 2020; 44(6): 371-378.

   5-7. Master M et al. series of MRI-based longevity studies (PRS 2021; PRS GO 2022; PRS GO 2024).